Anagre Cap.

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anagre Cap., covering 2021-07-21 to 2021-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Anagre Cap. in Patients With High-Risk Essential Thrombocythemia [Phase 4]